Goldman Sachs’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-363
| Closed | -$3.71K | – | 5282 |
|
|
2023
Q1 | $3.71K | Buy |
+363
| New | +$3.71K | ﹤0.01% | 5035 |
|
|
2022
Q1 | – | Sell |
-703
| Closed | -$76K | – | 5997 |
|
|
2021
Q4 | $76K | Buy |
703
+68
| +11% | +$7.35K | ﹤0.01% | 5280 |
|
|
2021
Q3 | $76K | Buy |
+635
| New | +$76K | ﹤0.01% | 5106 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$11K | – | 4669 |
|
|
2016
Q2 | $11K | Buy |
+1
| New | +$11K | ﹤0.01% | 4461 |
|